MammologixSM
MammoNavigateStandard Read

How the Supreme Court Just Saved Mammograms

RD

Richard D. Lippert, Jr.

B.S., (R.T.)(R)

June 30, 20253 min read
Breast cancer remains the second leading cause of cancer death among women in the United States, despite significant advances in early detection and treatment.
Share

But Why No Out-of-Pocket Costs Isn't Enough!

The Silent Crisis in Women's Health No One Is Talking About.

Breast cancer remains the second leading cause of cancer death among women in the United States, despite significant advances in early detection and treatment. Mammography, a proven tool for detecting cancer early, significantly reduces mortality by identifying tumors at more treatable stages. Yet about 32% of eligible women are not getting recommended screenings, even when mammograms are fully covered with no out-of-pocket costs. This gap highlights a critical public health challenge: ensuring that available preventive services are effectively utilized.

A recent Newsweek article [1] revealed that one in three women skip mammograms despite $0 copay coverage. Delayed screening increases treatment costs by 18%, with advanced cases reaching up to $120,000 per episode—far higher than the costs associated with early-stage treatment. Insurance leaders suggest that the main issue is not financial but rather communication. Many women remain unaware of their coverage or do not prioritize screening amid daily demands. As Chris Fong, CEO of Smile Insurance, noted, "The problem isn't that services like mammograms are not covered but more about communication."

The recent U.S. Supreme Court decision in Kennedy v. Braidwood Management, Inc. [2] added crucial context. On June 27, 2025, the Court upheld the Affordable Care Act's requirement for insurers to cover preventive services, including mammograms, without patient cost-sharing. This 6–3 decision was celebrated by public health organizations such as Susan G. Komen®, which called it a "monumental win for public health" that preserves access to lifesaving screenings and genetic testing. [3]

However, the ruling also confirmed that the Secretary of Health and Human Services (HHS) has significant authority over the U.S. Preventive Services Task Force (USPSTF), including the authority to appoint and remove members and review the Task Force's recommendations. This power introduces a risk that future political shifts could influence screening guidelines, potentially affecting who qualifies for coverage and how often women are advised to screen.

Meanwhile, data from the Annals of Internal Medicine [4] reveal a paradox. While many women avoid screening altogether, others receive annual mammograms despite biennial recommendations for specific age groups. In a national study of over 20,000 women without a history of breast cancer, 68.1% had mammography in the past two years and 75.2% of those reported annual exams. Over-screening can cause unnecessary anxiety, false positives, and potentially harmful interventions.

Thus, we face a dual challenge: underuse among some women and overuse among others. Addressing the 32% who remain unscreened requires more effective, culturally sensitive communication. Insurance companies and healthcare providers must work together to repeatedly emphasize that mammograms are both covered and crucial for survival.

Moreover, practical barriers such as transportation, caregiving responsibilities, and health literacy must be addressed through solutions like mobile mammography units, employer-supported screening days, and partnerships with community organizations.

Finally, ensuring that screening practices align with evidence-based guidelines is crucial to reducing over-screening and focusing resources on those who remain unscreened. Educating both providers and patients about appropriate intervals can improve resource allocation and protect women from unnecessary harm.

While the Supreme Court's decision safeguards access for now, the ongoing challenge is to close the utilization gap and prepare for potential future policy changes. By tackling communication failures, social barriers, and adherence to evidence-based guidelines, the healthcare community can improve breast cancer outcomes and save more lives.

Sources [1] Dutton, J. (2025, May 21). Why are women skipping their mammograms? Newsweek. https://www.newsweek.com/why-are-women-skipping-their-mammograms-2075355 [2] Kennedy v. Braidwood Management, Inc., 602 U.S. _ (2025). [3] Susan G. Komen. Susan G. Komen® applauds U.S. Supreme Court decision protecting no-cost access to lifesaving breast care. Komen.org. Published June 27, 2025. Accessed June 29, 2025. https://www.komen.org/news/susan-g-komen-applauds-u-s-supreme-court-decision-protecting-no-cost-access-to-lifesaving-breast-care/ [4] Dixit MN, Wolfson EA, Aliberti GM, Schonberg MA. Reported mammography screening interval by age among U.S. women: a national cross-sectional study. Ann Intern Med. Published online March 25, 2025. doi:10.7326/M24-0073

Mammologix Moments

About the Author

Richard “Rick” Lippert, Jr.

ARRT · President & Founder, Mammologix · Breast Imaging Operations since 1995

A registered radiologic technologist and founder of Mammologix, Rick Lippert has spent more than 30 years in breast imaging operations — from clinical practice and hospital radiology administration to building specialized service platforms for imaging centers nationwide. His work spans mammography tracking, lay communication, FDA/MQSA-related support, medical outcome audit, and the operational systems that help facilities stay compliant and keep patients from falling through the cracks.

Full credentials and background →

Disclaimer

The content, articles, calculators, tools, estimates, projections, derived data, reports, and other materials provided by Mammologix, LLC, powered by I/O Trak, Inc. (“Mammologix”) are provided for informational and educational purposes only.

The information and outputs provided by Mammologix are not intended to serve as, and should not be relied upon as, medical advice, diagnosis, treatment, clinical guidance, financial advice, investment advice, tax advice, legal advice, accounting advice, or any other professional advice.

Information provided by Mammologix may relate to breast health, mammography, imaging, screening, diagnostics, clinical outcomes, healthcare topics, financial calculations, estimates, projections, or other decision-support information. However, such information should not be used to make personal medical, clinical, financial, investment, business, insurance, legal, or other important decisions without consulting an appropriate qualified professional.

Always seek the advice of a licensed physician, radiologist, healthcare provider, financial advisor, accountant, attorney, or other qualified professional with any questions you may have about a medical condition, screening recommendation, imaging result, treatment option, financial matter, or other professional decision. Never disregard professional medical, financial, legal, or other advice, or delay seeking such advice, because of something you have read, calculated, or received through Mammologix.

Any calculators, formulas, estimates, projections, derived medical outcome data, financial calculations, or other tool-generated outputs are provided as estimates only. Results may be affected by user-entered information, assumptions, formula limitations, incomplete or inaccurate data, rounding, software errors, third-party data, changing medical guidelines, changing financial conditions, changes in law or regulation, or other factors. Mammologix does not represent, warrant, or guarantee that any calculation, output, article, estimate, projection, or derived data is accurate, complete, current, reliable, suitable, or appropriate for any particular purpose.

For medical or health-related content and calculators, Mammologix does not provide medical advice, diagnosis, treatment recommendations, diagnostic interpretation, or patient-specific clinical decision-making. Mammologix content and tools are not a substitute for an in-person evaluation, professional medical consultation, diagnostic interpretation, or individualized care from a licensed healthcare provider. In the event of a medical emergency, contact emergency services or a qualified healthcare provider immediately.

For financial, business, tax, investment, or accounting-related calculators or content, Mammologix does not provide financial, investment, tax, legal, accounting, or business advice. Any outputs are estimates only, and actual results may vary materially based on personal circumstances, market conditions, taxes, fees, interest rates, inflation, risk tolerance, regulatory changes, and other factors.

Use of Mammologix content, articles, calculators, tools, and outputs is at your own risk. You are solely responsible for reviewing, verifying, and interpreting any information or results provided and for obtaining appropriate professional advice before relying on or acting upon such information.

Mammologix assumes no liability for any injury, loss, claim, damage, or expense arising from or related to the use of, reliance on, or inability to use any Mammologix content, article, calculator, tool, estimate, projection, derived data, report, or website material. To the fullest extent permitted by law, Mammologix, its owners, officers, employees, contractors, affiliates, licensors, service providers, and agents disclaim all liability for any direct, indirect, incidental, consequential, special, exemplary, punitive, financial, medical, clinical, business, or other damages arising out of or relating to the use of Mammologix materials or outputs.

The information provided by Mammologix does not establish a doctor-patient, provider-patient, radiologist-patient, financial advisor-client, attorney-client, accountant-client, fiduciary, or other professional relationship.

AI Content Disclosure

Some Mammologix content, calculations, summaries, tools, or outputs may be created, edited, generated, or assisted by artificial intelligence tools or automated systems. While Mammologix may review content for accuracy and relevance, AI-assisted or automated materials may contain errors, omissions, inaccuracies, outdated information, or outputs that are incomplete or inappropriate for a particular user, patient, circumstance, or purpose.

Users should independently verify all AI-assisted content, calculator outputs, and automated results with appropriate qualified professionals before relying on them.

Keep Reading

Related Resources

See how Mammologix puts this into practice

Real operational support for breast imaging centers.